Insider buying
~$47K2,632 sh @ $18.00
Traded Sep 27, 2024 · filed 164 days later
Bioage Labs's Principal Accounting Officer paid $47K out of pocket for Bioage Labs shares. 3 other people at Bioage Labs bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
2 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Reduced
Compared with the manager's Q3 2024 13F
1,423,470
921,959
−35.2%
Share count drives classification; reported value also moves with price
0.11%
Within the filing's reported positions, not the manager's total assets
2
For Q4 2024
Insider buying
Traded Sep 27, 2024 · filed 164 days later
Bioage Labs's Principal Accounting Officer paid $47K out of pocket for Bioage Labs shares. 3 other people at Bioage Labs bought some too, in the same month.
Insider buying
Traded Sep 27, 2024 · filed 164 days later
A Bioage Labs director paid $54K out of pocket for Bioage Labs shares. 3 other people at Bioage Labs bought some too, in the same month.
Fund moves
3 tracked managers disclosed the same change for Q4 2024. From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.